Evaluating equitable access based on sociodemographic predictors of nirmatrelvir-ritonavir use during the first year of availability in Ontario, Canada: A population-based ecological study.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/41973385

Bradley J Langford; Cynthia Chen; Jun Wang; Kevin A Brown; Kevin L Schwartz; Lindsay Friedman; Meagan Lacroix; Mina Tadrous; Nick Daneman; Peter Daley; Tara Gomes; Valerie Leung

Apr 13, 2026